Cambridge Advisors’s Abbott ABT Stock Holding History

Cambridge Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587K	Sell	6,470 -250	-4%	-$22.8K	0.1%	115
2026 Q1	$690K	Sell	6,720 -25	-0.4%	-$2.82K	0.13%	102
2025 Q4	$845K	Hold	6,745	–	–	0.16%	91
2025 Q3	$903K	Sell	6,745 -122	-2%	-$16K	0.18%	85
2025 Q2	$934K	Buy	6,867 +22	+0.3%	+$2.9K	0.2%	78
2025 Q1	$908K	Hold	6,845	–	–	0.2%	80
2024 Q4	$774K	Sell	6,845 -250	-4%	-$28.9K	0.17%	88
2024 Q3	$809K	Sell	7,095 -150	-2%	-$16.5K	0.18%	85
2024 Q2	$753K	Sell	7,245 -25	-0.3%	-$2.65K	0.17%	90
2024 Q1	$826K	Sell	7,270 -475	-6%	-$54.5K	0.19%	83
2023 Q4	$852K	Sell	7,745 -200	-3%	-$20K	0.21%	76
2023 Q3	$769K	Hold	7,945	–	–	0.21%	82
2023 Q2	$866K	Sell	7,945 -745	-9%	-$79.4K	0.22%	75
2023 Q1	$880K	Hold	8,690	–	–	0.23%	74
2022 Q4	$954K	Sell	8,690 -200	-2%	-$20.7K	0.26%	64
2022 Q3	$860K	Hold	8,890	–	–	0.25%	68
2022 Q2	$966K	Sell	8,890 -145	-2%	-$16.5K	0.26%	63
2022 Q1	$1.07M	Sell	9,035 -50	-0.6%	-$6.2K	0.25%	64
2021 Q4	$1.28M	Hold	9,085	–	–	0.29%	63
2021 Q3	$1.07M	Sell	9,085 -700	-7%	-$86K	0.26%	69
2021 Q2	$1.13M	Sell	9,785 -305	-3%	-$35.6K	0.27%	66
2021 Q1	$1.21M	Hold	10,090	–	–	0.31%	56
2020 Q4	$1.1M	Hold	10,090	–	–	0.3%	59
2020 Q3	$1.1M	Sell	10,090 -100	-1%	-$10.1K	0.32%	54
2020 Q2	$932K	Hold	10,190	–	–	0.29%	60
2020 Q1	$804K	Hold	10,190	–	–	0.29%	58
2019 Q4	$885K	Buy	+10,190	New	+$853K	0.27%	68
2019 Q3	–	Sell	-10,365	Closed	-$872K	–	133
2019 Q2	$872K	Sell	10,365 -575	-5%	-$45.3K	0.29%	62
2019 Q1	$875K	Hold	10,940	–	–	0.3%	61
2018 Q4	$791K	Hold	10,940	–	–	0.29%	61
2018 Q3	$803K	Hold	10,940	–	–	0.27%	67
2018 Q2	$667K	Hold	10,940	–	–	0.24%	77
2018 Q1	$656K	Sell	10,940 -70	-0.6%	-$4.22K	0.24%	77
2017 Q4	$628K	Hold	11,010	–	–	0.23%	76
2017 Q3	$587K	Hold	11,010	–	–	0.23%	73
2017 Q2	$535K	Sell	11,010 -1,400	-11%	-$63.4K	0.22%	74
2017 Q1	$551K	Sell	12,410 -200	-2%	-$8.65K	0.23%	77
2016 Q4	$484K	Sell	12,610 -150	-1%	-$5.95K	0.21%	83
2016 Q3	$540K	Hold	12,760	–	–	0.24%	76
2016 Q2	$502K	Hold	12,760	–	–	0.23%	78
2016 Q1	$534K	Hold	12,760	–	–	0.25%	75
2015 Q4	$573K	Hold	12,760	–	–	0.32%	66
2015 Q3	$513K	Sell	12,760 -150	-1%	-$7.07K	0.3%	70
2015 Q2	$634K	Hold	12,910	–	–	0.36%	65
2015 Q1	$598K	Hold	12,910	–	–	0.35%	64
2014 Q4	$581K	Buy	+12,910	New	+$562K	0.36%	66

Other funds holding ABT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Cambridge Advisors's ABT Position: Q2 2026 in Review

Cambridge Advisors reduced its Abbott (ABT) stake by 3.7% in Q2 2026, selling an estimated $22.8K and leaving 6,470 shares worth $587K. The position accounts for 0.1% of the portfolio, ranked #115.

Cambridge Advisors first reported a position in ABT in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.28M in Q4 2021. 759 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Cambridge Advisors held 6,470 shares of Abbott worth $587K as of Q2 2026.
Cambridge Advisors sold 250 Abbott shares in Q2 2026, an estimated $22.8K.
Abbott made up 0.1% of Cambridge Advisors's portfolio in Q2 2026, its #115 holding.
Cambridge Advisors first reported a position in Abbott in Q4 2014 and has held it in 46 quarters since.
Cambridge Advisors's Abbott position peaked at $1.28M in Q4 2021.
759 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cambridge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.